One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Cytokinetics (CYTK) cleared that benchmark Monday, with a jump from 78 to 83 Monday. Hone Your Stock-Picking Skills By Focusing On These Factors IBD's proprietary RS Rating identifies market leadership by showing how a stock's price movement over the last 52 weeks compares…